STANDARD PRECAUTIONS STORAGE AND WARNING: For External use only
Established Safety Profile Across all clinical studies, AOD-9604 demonstrated excellent safety and tolerability
Each is Janoshik tested with independently verifiable COAs
Do NOT Start TRT (or proceed only with specialist clearance) If You Have Per Endocrine Society guidance, TRT is contraindicated or requires caution in men with: Prostate cancer, breast cancer, or a suspicious prostate exam / improved PSA (PSA above ~4 ng/mL, or above ~3 ng/mL if at higher risk, without urology evaluation) High hematocrit / polycythemia (blood that is too thick, raises clot risk) Untreated severe obstructive sleep apnea Uncontrolled heart failure , or a heart attack or stroke in the past 6 months A known clotting disorder (thrombophilia) or history of blood clots Severe urinary symptoms from an enlarged prostate Men actively trying to conceive in the near term , TRT suppresses sperm production Peptides Are Not Appropriate If You Have Active cancer or a recent cancer history , raising GH/IGF-1 is a theoretical concern where cell growth is involved Diabetes or insulin resistance , GH secretagogues can raise blood sugar Any situation where unverified sourcing cannot be ruled out Side Effects and Red Flags TRT Side Effects Common and manageable with dose adjustment and monitoring: Polycythemia (thicker blood from a rising red-cell count), the most important reason for regular blood tests Acne / oily skin Gynecomastia (breast-tissue enlargement, from testosterone converting to estrogen) Testicular shrinkage and reduced fertility Fluid retention , mood changes, sleep-apnea worsening Regulators have updated testosterone product labels to warn of venous blood clots (DVT/PE) and increased blood pressure , independent of polycythemia
